US Stock MarketDetailed Quotes

Vaccinex (VCNX)

Watchlist
  • 1.333
  • 0.0000.00%
15min DelayClose Jan 22 15:52 ET
3.57MMarket Cap-0.15P/E (TTM)

Vaccinex (VCNX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
5.44%601K
213K
160.00%52K
232K
-81.09%104K
107.27%570K
0
-60.00%20K
0
550K
Operating revenue
5.44%601K
--213K
160.00%52K
--232K
-81.09%104K
107.27%570K
--0
-60.00%20K
--0
--550K
Cost of revenue
Gross profit
Operating expense
-17.56%19.34M
-27.83%3.6M
-21.35%4.6M
-15.87%5.95M
-6.47%5.18M
16.22%23.46M
-6.66%4.99M
20.90%5.85M
31.03%7.08M
20.51%5.54M
Selling and administrative expenses
-1.31%6.79M
-10.06%1.47M
-4.00%1.44M
3.11%2.09M
4.12%1.8M
10.95%6.88M
1.75%1.63M
6.09%1.5M
30.10%2.03M
5.90%1.72M
-General and administrative expense
-1.31%6.79M
-10.06%1.47M
-4.00%1.44M
3.11%2.09M
4.12%1.8M
10.95%6.88M
1.75%1.63M
6.09%1.5M
30.10%2.03M
5.90%1.72M
Research and development costs
-24.31%12.55M
-36.46%2.13M
-27.32%3.17M
-23.49%3.86M
-11.25%3.38M
18.56%16.57M
-10.26%3.36M
27.00%4.36M
31.41%5.05M
28.52%3.81M
Operating profit
18.13%-18.74M
32.10%-3.39M
21.97%-4.55M
19.15%-5.72M
-1.76%-5.07M
-14.97%-22.89M
2.56%-4.99M
-21.74%-5.83M
-31.03%-7.08M
-8.53%-4.99M
Net non-operating interest income expense
-100.00%-2K
-2K
0
0
-28K
50.00%-1K
0
0
0
0
Non-operating interest expense
100.00%2K
--2K
--0
--0
--28K
-50.00%1K
--0
--0
--0
--0
Other net income (expense)
-96.09%103K
-99.10%15K
-227.98%-1.18M
435.29%91K
4,920.83%1.21M
2,733.33%2.64M
3,975.61%1.67M
2,611.76%922K
-10.53%17K
24K
Gain on sale of security
-96.40%62K
---14K
---1.18M
--75K
--1.21M
--1.72M
----
----
----
----
Other non- operating income (expenses)
-95.50%41K
155.77%29K
-100.33%-3K
-5.88%16K
-104.17%-1K
880.65%912K
-226.83%-52K
2,611.76%922K
-10.53%17K
--24K
Income before tax
7.98%-18.63M
-1.72%-3.37M
-16.69%-5.73M
20.24%-5.63M
21.46%-3.9M
-2.20%-20.25M
34.68%-3.32M
-3.21%-4.91M
-31.15%-7.06M
-7.99%-4.96M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
7.98%-18.63M
-1.72%-3.37M
-16.69%-5.73M
20.24%-5.63M
21.46%-3.9M
-2.20%-20.25M
34.68%-3.32M
-3.21%-4.91M
-31.15%-7.06M
-7.99%-4.96M
Net income continuous Operations
7.98%-18.63M
-1.72%-3.37M
-16.69%-5.73M
20.24%-5.63M
21.46%-3.9M
-2.20%-20.25M
34.68%-3.32M
-3.21%-4.91M
-31.15%-7.06M
-7.99%-4.96M
Minority interest income
Net income attributable to the parent company
7.98%-18.63M
-1.72%-3.37M
-16.69%-5.73M
20.24%-5.63M
21.46%-3.9M
-2.20%-20.25M
34.68%-3.32M
-3.21%-4.91M
-31.15%-7.06M
-7.99%-4.96M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
7.98%-18.63M
-1.72%-3.37M
-16.69%-5.73M
20.24%-5.63M
21.46%-3.9M
-2.20%-20.25M
34.68%-3.32M
-3.21%-4.91M
-31.15%-7.06M
-7.99%-4.96M
Basic earnings per share
79.67%-8.88
66.08%-1.2605
81.44%-2.83
87.37%-3.1
85.93%-2.94
55.45%-43.68
84.04%-3.716
34.77%-15.25
10.11%-24.54
17.10%-20.89
Diluted earnings per share
79.67%-8.88
66.08%-1.2605
81.44%-2.83
87.37%-3.1
85.93%-2.94
55.45%-43.68
84.04%-3.716
34.77%-15.25
10.11%-24.54
17.10%-20.89
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 5.44%601K213K160.00%52K232K-81.09%104K107.27%570K0-60.00%20K0550K
Operating revenue 5.44%601K--213K160.00%52K--232K-81.09%104K107.27%570K--0-60.00%20K--0--550K
Cost of revenue
Gross profit
Operating expense -17.56%19.34M-27.83%3.6M-21.35%4.6M-15.87%5.95M-6.47%5.18M16.22%23.46M-6.66%4.99M20.90%5.85M31.03%7.08M20.51%5.54M
Selling and administrative expenses -1.31%6.79M-10.06%1.47M-4.00%1.44M3.11%2.09M4.12%1.8M10.95%6.88M1.75%1.63M6.09%1.5M30.10%2.03M5.90%1.72M
-General and administrative expense -1.31%6.79M-10.06%1.47M-4.00%1.44M3.11%2.09M4.12%1.8M10.95%6.88M1.75%1.63M6.09%1.5M30.10%2.03M5.90%1.72M
Research and development costs -24.31%12.55M-36.46%2.13M-27.32%3.17M-23.49%3.86M-11.25%3.38M18.56%16.57M-10.26%3.36M27.00%4.36M31.41%5.05M28.52%3.81M
Operating profit 18.13%-18.74M32.10%-3.39M21.97%-4.55M19.15%-5.72M-1.76%-5.07M-14.97%-22.89M2.56%-4.99M-21.74%-5.83M-31.03%-7.08M-8.53%-4.99M
Net non-operating interest income expense -100.00%-2K-2K00-28K50.00%-1K0000
Non-operating interest expense 100.00%2K--2K--0--0--28K-50.00%1K--0--0--0--0
Other net income (expense) -96.09%103K-99.10%15K-227.98%-1.18M435.29%91K4,920.83%1.21M2,733.33%2.64M3,975.61%1.67M2,611.76%922K-10.53%17K24K
Gain on sale of security -96.40%62K---14K---1.18M--75K--1.21M--1.72M----------------
Other non- operating income (expenses) -95.50%41K155.77%29K-100.33%-3K-5.88%16K-104.17%-1K880.65%912K-226.83%-52K2,611.76%922K-10.53%17K--24K
Income before tax 7.98%-18.63M-1.72%-3.37M-16.69%-5.73M20.24%-5.63M21.46%-3.9M-2.20%-20.25M34.68%-3.32M-3.21%-4.91M-31.15%-7.06M-7.99%-4.96M
Income tax 0000000000
Net income 7.98%-18.63M-1.72%-3.37M-16.69%-5.73M20.24%-5.63M21.46%-3.9M-2.20%-20.25M34.68%-3.32M-3.21%-4.91M-31.15%-7.06M-7.99%-4.96M
Net income continuous Operations 7.98%-18.63M-1.72%-3.37M-16.69%-5.73M20.24%-5.63M21.46%-3.9M-2.20%-20.25M34.68%-3.32M-3.21%-4.91M-31.15%-7.06M-7.99%-4.96M
Minority interest income
Net income attributable to the parent company 7.98%-18.63M-1.72%-3.37M-16.69%-5.73M20.24%-5.63M21.46%-3.9M-2.20%-20.25M34.68%-3.32M-3.21%-4.91M-31.15%-7.06M-7.99%-4.96M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 7.98%-18.63M-1.72%-3.37M-16.69%-5.73M20.24%-5.63M21.46%-3.9M-2.20%-20.25M34.68%-3.32M-3.21%-4.91M-31.15%-7.06M-7.99%-4.96M
Basic earnings per share 79.67%-8.8866.08%-1.260581.44%-2.8387.37%-3.185.93%-2.9455.45%-43.6884.04%-3.71634.77%-15.2510.11%-24.5417.10%-20.89
Diluted earnings per share 79.67%-8.8866.08%-1.260581.44%-2.8387.37%-3.185.93%-2.9455.45%-43.6884.04%-3.71634.77%-15.2510.11%-24.5417.10%-20.89
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More